Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40YEM | ISIN: US19207A2078 | Ticker-Symbol:
NASDAQ
06.06.25 | 15:30
8,700 US-Dollar
-1,69 % -0,150
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COEPTIS THERAPEUTICS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
COEPTIS THERAPEUTICS HOLDINGS INC 5-Tage-Chart

Aktuelle News zur COEPTIS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCoeptis Therapeutics Holdings, Inc. - 10-K/A, Annual Report1
28.05.Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology1
14.05.Coeptis Therapeutics Holdings, Inc. - 10-Q, Quarterly Report2
26.04.Coeptis Therapeutics Holdings, Inc. - 8-K, Current Report-
25.04.Coeptis Flops on Merger with Z Squared1
25.04.Coeptis, Dogecoin Mining Firm Z Squared To Merge; To Spin Out Biopharma Unit; Stock Down1
25.04.Coeptis Therapeutics, Z Squared announce merger agreement1
COEPTIS THERAPEUTICS Aktie jetzt für 0€ handeln
25.04.Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement165WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative...
► Artikel lesen
17.04.COEPTIS kündigt strategischen Technologie-Hub in Indien an1
17.04.COEPTIS announces strategic tech hub in India1
17.04.Coeptis Therapeutics: COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology3
04.04.Coeptis Therapeutics Holdings, Inc. - S-1/A, General form for registration of securities2
27.03.Coeptis Therapeutics Holdings, Inc. - 8-K, Current Report1
11.03.Coeptis forms subsidiary to advance cancer cell therapy2
11.03.Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline1
07.03.Coeptis Therapeutics: COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan13
07.03.NUBURU partners with COEPTIS NexGenAI Affiliates Network8
19.02.Coeptis und MarketLeverage kooperieren für KI-gestütztes Marketing1
19.02.Coeptis, MarketLeverage partner for AI-driven marketing1
19.02.Coeptis Therapeutics: COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing1
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1